Harmony Biosciences (HRMY)
Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation
Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation
📈 **POSITIVE** • High confidence analysis (94%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business